Sargent Investment Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Sell |
10,000
-500
| -5% | -$14.3K | 0.04% | 197 |
|
|
2025
Q1 | $203K | Sell |
10,500
-70,000
| -87% | -$1.35M | 0.03% | 221 |
|
|
2024
Q4 | $1.46M | Hold |
80,500
| – | – | 0.24% | 77 |
|
|
2024
Q3 | $1.76M | Buy |
80,500
+8,500
| +12% | +$186K | 0.32% | 64 |
|
|
2024
Q2 | $562K | Buy |
72,000
+62,000
| +620% | +$484K | 0.11% | 112 |
|
|
2024
Q1 | $41.4K | Hold |
10,000
| – | – | 0.01% | 200 |
|
|
2023
Q4 | $26.1K | Hold |
10,000
| – | – | 0.01% | 208 |
|
|
2023
Q3 | $18.7K | Hold |
10,000
| – | – | ﹤0.01% | 202 |
|
|
2023
Q2 | $25.1K | Buy |
+10,000
| New | +$25.1K | 0.01% | 198 |
|